iShares MSCI Malaysia ETF vs Philip Morris International Inc. — how do they compare? iShares MSCI Malaysia ETF trades at $28.05, while Philip Morris International Inc. trades at $187.66 (market cap $281.91B). The key difference: Philip Morris International Inc. pays a 3.25% dividend while iShares MSCI Malaysia ETF pays none, and Philip Morris International Inc. is trading nearer its 52-week high, iShares MSCI Malaysia ETF nearer its low. Which is the better fit depends on your goals.
| EWM | PM | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $30.42 | $191.86 |
52-Week Low | $23.49 | $144.33 |
Market Cap | — | $281.91B |
Enterprise Value | — | $328.41B |
Dividend Yield | — | 3.25% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $175.95, down 2.35% amid a bearish technical signal and recent profit forecast revision. The company reported strong Q1 2026 EPS of $1.96, beating estimates, but faces headwinds from a $500 million impairment charge and margin pressures. Revenue growth remains steady, with 2025 revenue at $40.65 billion and net income margin of 26.74%. Analyst consensus is bullish with a $194 price target, though technical indicators show resistance near $179.
The stock presents a mixed outlook: solid fundamentals and high analyst buy ratings support upside potential, but near-term risks include cost pressures, currency volatility, and illicit market growth. Long-term investors may find value in the dividend and brand strength, while caution is warranted due to regulatory and macroeconomic challenges.
Trailing returns across standard periods
EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.
Read more on EWM →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →